×
Eagle Pharmaceuticals Net Profit Margin 2013-2023 | EGRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Eagle Pharmaceuticals net profit margin from 2013 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Historical Chart (TTM)
Quarterly
Annual
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$198.1B
Stryker (SYK)
$139B
Boston Scientific (BSX)
$131.1B
EssilorLuxottica (ESLOY)
$109.9B
Medtronic (MDT)
$103.9B
Haleon (HLN)
$43.9B
Lonza Group Ag (LZAGY)
$42.9B
GE HealthCare Technologies (GEHC)
$36.1B
ResMed (RMD)
$34.8B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$23.6B
Zimmer Biomet Holdings (ZBH)
$21.3B
Insulet (PODD)
$18.7B
Baxter (BAX)
$15.1B
Smith & Nephew SNATS (SNN)
$10.8B
BellRing Brands (BRBR)
$9.8B
Bio-Rad Laboratories (BIO)
$9.2B
Demant (WILYY)
$7.9B
Lantheus Holdings (LNTH)
$6.2B
Prestige Consumer Healthcare (PBH)
$3.9B
ICU Medical (ICUI)
$3.8B
Haemonetics (HAE)
$3.8B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.2B
QuidelOrtho (QDEL)
$3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
Neogen (NEOG)
$2.6B
LeMaitre Vascular (LMAT)
$2.1B
Green Thumb Industries (GTBIF)
$1.7B